Fulgent Genetics Inc (FLGT)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 2,964 | 3,372 | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,136,100 | 1,266,680 | 1,158,750 | 569,387 | 82,777 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $2,964K ÷ $1,136,100K
= 0.00
The debt-to-equity ratio of Fulgent Genetics Inc has shown a consistently low and stable trend over the past five years, ranging from 0.00 to 0.03. This indicates that the company relies more on equity financing rather than debt to fund its operations and growth. A ratio of 0.00 in 2023 suggests an absence of debt in the company's capital structure, reflecting a strong financial position with minimal financial leverage. The slight increase in the ratio from 0.00 in 2019 to 0.03 in 2020 may indicate a minor shift towards using debt for financing, but it still remains at a relatively low level. Overall, the company's conservative approach towards debt management is reflected in its stable and low debt-to-equity ratio over the years.
Peer comparison
Dec 31, 2023